Ho Chi Minh City, May 27, 2025 | Leaders from both companies, including STADA Pymepharco General Manager, Philippe Gautron, Commercial Head Tran Hoang Y Yen, and Buymed’s senior representatives gathered at Buymed headquarters to formalize a comprehensive strategic agreement. This collaboration aims to enhance healthcare access by integrating high-quality pharmaceutical manufacturing with advanced digital distribution capabilities.
As one of Vietnam’s leading pharmaceutical manufacturers, STADA Pymepharco offers one of the most extensive portfolios of EU-GMP certified products among international and domestic industry players, along with a commitment to ‘German standard’ healthcare. As the sole wholly owned affiliate of STADA Group in Vietnam, quality and innovation in pharmaceutical manufacturing remain our top priorities.
Buymed, with its pioneering digital platform thuocsi.vn, has significantly reshaped pharmaceutical distribution in Vietnam. With a robust network of over 35,000 pharmacies and healthcare providers, Buymed ensures efficient, transparent, and tech-enabled delivery of medical products.
And this is precisely where our paths converge – through a shared Growth Mindset and an Entrepreneurship vision. By uniquely blending STADA Pymepharco’s manufacturing excellence with Buymed’s digital leadership, we aim to:
🌍 Expand timely access to essential medicine, even for the most remote areas.
⚙️ Boost efficiency by streamlining supply chains, shortening delivery times, and ensuring product authenticity through advanced digital tracking
♻️ Drive sustainability in the pharmaceutical market by eliminating redundancies and facilitating direct manufacturer-to-pharmacy distribution.
At the core of this partnership lies our mutual dedication to improving community health outcomes. By combining our complementary strengths, we aspire to make high-quality healthcare more accessible and affordable for all citizens in Vietnam.
We eagerly anticipate the positive impact of this collaboration and look forward to an exciting journey ahead!
Read more about STADA Pymepharco: | |||||||||||||||
|
|
|
|
|
|
|
|
|
| ||||||